Rachel Kuchtey

New findings highlight microRNAs — molecules that regulate gene expression — that are differentially expressed in glaucoma and could be candidate biomarkers or targets for therapy. Read More

Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment. Read More

Researchers have identified a new candidate gene for the most common form of glaucoma, which runs in families. The findings offer novel insights into glaucoma pathology and could lead to targeted treatment strategies. Read More